Primaire tabs

Zoeken
Limit to
Exporteer 74 resultaten:
Filters: Auteur is L. Tesolin
2022
The change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine, Q&A, Tesolin, L., and Bruysters M. , OMCL annual meeting 2022, 16/06/2022, EDQM, strasbourg, (2022)
Concept paper on the change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine, Tesolin, L., and Bruysters M. , 06/04/2022, Strasbourg, France, p.5, (2022)
The consistency approach for the substitution of in vivo testing for the quality control of established vaccines: practical considerations and progressive vision, Tesolin, L., Dierick J.-F., and Van Molle Wim , Open Research Europe, 13/12/2022, (2022)
Manufacture and control of vaccine adjuvants from OMCL perspective, Tesolin, L. , Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
OCABR guideline for inactivated COVID-19 vaccines, Pullirsch, D., Campitelli L., Bruysters M., Tesolin L., Oppling V., and Garcia D. , 16/11/2022, EDQM, strasbourg, p.12, (2022)
Training on biological methods (Immunology), Auquier, J., Domicent C., Masquelier F., Clouet S., and Tesolin L. , 13/10/2022, Sciensano, Bruxelles, (2022)
The vaccine Batch release procedure in Europe, Tesolin, L. , Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
"WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines", Lei, D., Meyer H., Jivapaisarnpong T., and Tesolin L. , "WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines", 08/11/2022, Mascate, Oman sultanate, (2022)
Workshop on implementation of single dilution assay for in vivo testing, Ribaucour, F, Florens Morgane, and Tesolin L. , Workshop on implementation of single dilution assay for in vivo testing, 22/11/2022, Brussels, Belgium, (2022)
2021
The batch release procedure in Europe ; Bacterial and polysaccharide vaccines, Tesolin, L. , ULB dept Pharmacy, (2021)
The batch release procedure in Europe; manufacture and control of vaccine adjuvants; bacterial and polysaccharide vaccines, Tesolin, L. , ULB dept Pharmacy, (2021)
Evaluation of OCBAR testing of recombinant vaccine at bulk monovalent stage, Tesolin, L. , OMCL annual meeting, (2021)
Evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases: regulatory considerations, Tesolin, L., Van Molle Wim, and Brusselmans Koen , (2021)
Guideline for Pandemic COVID-19 Vaccine (mRNA), Tesolin, L. , 01/05/2021, EDQM, strasbourg, p.16, (2021)
Guideline for Pandemic COVID-19 Vaccine (Non-replicating Adenovirus-vectored vaccine), Tesolin, L. , 01/04/2021, EDQM, strasbourg, p.13, (2021)
Guideline for Pandemic COVID-19 Vaccine (Recombinant Spike Protein), Tesolin, L. , EDQM, strasbourg, p.17, (2021)
How to implement trend analysis, Tesolin, L., Waeterloos Geneviève, Stradiot L., Ribaucour F, Auquier J., and Cuignet L. , Training Saudi Food and Drug Authority, (2021)
Libération des lots de vaccins, Tesolin, L. , Training Senegal Agency, (2021)
Panel discussion official forum Taiwan FDA to share/discuss about COVID-19 vaccine testing, medicines quality issues, and batch release procedures, Tesolin, L. , Taiwan FDA to share/discuss about COVID-19 vaccine testing, medicines quality issues, and batch release procedures , 26/10/2021, Taiwan, (2021)
Roadmap from the classical control strategy of vaccines to the consistency testing based control strategy, Tesolin, L. , VAC2VAC Workshop 24 June 2021, (2021)
RSV vaccine GSK : OCABR testing, Tesolin, L. , EDQM OCABR drafting group, 19/10/2021, EDQM, Strasbourg, (2021)

QR code

QR code for this page URL